On January 16, 2026, State Street (NYSE: STT) fell 3.5% to $131.48 as of 10:20 AM EST, down from a $136.20 prior close, despite topping Q4 EPS and revenue estimates. Investors focused on $226 million in repositioning charges and a 2026 expense outlook of 3–4%, above Visible Alpha's 1.6% consensus, alongside a low single-digit net interest income guide.

QXO, Inc. slid in premarket trading on January 16, 2026 after it priced a public offering of 31,645,570 shares at $23.80, about a 6.7% discount to the prior $25.52 close. The stock traded at $23.44, down $1.58 or 6.31% as of 8:18 AM EST. The deal is expected to close on January 20, 2026, with BofA Securities as sole underwriter and an option for up to 4,746,835 additional shares.

On Thursday, January 15, 2026, Morgan Stanley shares rose over 4%, closing at $189.52 after a prior $180.78, as the bank's Q4 results topped forecasts. It reported $2.68 EPS and $17.89 billion in revenue, with investment banking revenue up 47% to $2.41 billion and debt underwriting up nearly 93% to $785 million.

Boston Scientific said on Thursday, January 15, 2026, that it will acquire Penumbra in a cash-and-stock deal valuing the target at about $14.5 billion, or $374 per share, a roughly 19% premium. Following the announcement, Boston Scientific's stock slid 3.61% in premarket trading to $90.35, while Penumbra shares jumped in early action.

On January 15, 2026, Ocular Therapeutix stock climbed about 18% in premarket trading to $13.11 after the company rejected a $16 per share acquisition proposal from Sanofi. The move, backed by a strong cash position and a late-stage pipeline led by AXPAXLI (OTX-TKI), has reinforced investor expectations for upcoming Phase 3 trial readouts in wet age-related macular degeneration.

On January 15, 2026, TSMC shares climbed 5.76% in premarket trading to US$345.98 after the company reported record Q4 2025 results and raised its 2026 capex guidance to US$52–56 billion. The chipmaker posted net income of NT$505.74 billion, a 35% year-on-year increase, alongside strong revenue growth and margins supported by AI chip demand.

Drone warfare and related defense spending expanded through 2025, while some listed drone and battery names still trade below analyst price targets. Amprius Technologies and Unusual Machines both reported improving fundamentals and new defense-related opportunities, yet their current share prices imply sizeable upside relative to published forecasts. Both companies remain in focus as investors track growth in military and commercial unmanned systems heading into 2026.

Walmart shares rose 3.46% to $118.49 in premarket trading on January 12, 2026 after revealing a partnership with Google to surface Walmart and Sam's Club products inside the Gemini AI assistant. Announced January 11, 2026 at NRF's Big Show, the integration supports agent-led commerce and a U.S. rollout first, with terms and timelines undisclosed.

D-Wave Quantum said Wednesday it will acquire Quantum Circuits in a $550 million deal, split between $250 million cash and $300 million in QBTS stock. The move adds error-corrected, gate-model capabilities to D-Wave’s annealing portfolio and marks its first acquisition since listing in August 2022. Shares have risen sharply over the past year.